Matinas BioPharma Investor Presentation Deck
19
LNC Therapeutic Cargo Experience to Date
Infection
Inflammation
Oncology
In Vivo Animal Studies
Animal model
Cystic fibrosis mouse model
BALB/c mouse flu model
[Multiple mouse fungal models]
Pneumocystis mouse model
Mouse SARS-CoV-2 model
Rat footpad inflammation model
GvHD mouse model
LPS mouse model
Psoriasis (IMQ) mouse model*
DSS colitis mouse model*
Lymphocytic leukemia mouse model
Syngeneic mouse melanoma model*
Cargo
Amikacin
ASO
Flu protein
siRNA
Amphotericin- B
Atovaquone
Remdesivir
NSAID
ST1959
RNAi
RNAi
RNAi
ASO
Docetaxel
COPYRIGHT MATINAS BIOPHARMA
2024
Indication
Mucocutaneous
candidiasis
Job's syndrome, NIH
Vulvovaginal Candidiasis
(VVC) Phase 2
HIV/ cryptococcal
meningitis, Phase 2
* new
Human Clinical Trials
*
new
* new
Cargo
Amphotericin - B
Amphotericin - B
Amphotericin - B
MATINAS
BIOPHARMAView entire presentation